Medicines Transparency Alliance (MeTA): pathways to transparency, accountability an access: cross-case analysis and review of phase II / Tarin Vian … [et al]
World Health Organization. (2016). Medicines Transparency Alliance (MeTA): pathways to transparency, accountability an access: cross-case analysis and review of phase II / Tarin Vian … [et al]. World Health Organization. http://www.who.int/iris/handle/10665/246257
MetadataShow full item record
Showing items related by title and MeSH subject.
World Health Organization. Regional Office for South-East Asia (SEA/RC70/6, 2017)The purpose of this Agenda item is to update Member States on the various initiatives undertaken by the Organization and the South-East Asia (SEA) Region to reaffirm and strengthen transparency, accountability, enhanced compliance, risk management and adherence to ethical principles across the Organization. This working paper aims to stimulate deliberation and dialogue among Member States to further strengthen transparency, accountability, monitoring and evaluation within the SEA Region by (i) actively engaging Member States at the Regional ...
World Health Organization, Regional Office for the Eastern Mediterranean (2009)In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing ...